Anti-SARS-CoV-2 T-stem cell memory persists in ocrelizumab-treated MS patients
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Anti-SARS-CoV-2 T-stem cell memory persists in ocrelizumab-treated MS patients
Authors
Keywords
-
Journal
Multiple Sclerosis Journal
Volume -, Issue -, Pages 135245852211021
Publisher
SAGE Publications
Online
2022-06-20
DOI
10.1177/13524585221102158
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cellular and Humoral Immunity to SARS‐CoV‐2 Infection in Multiple Sclerosis Patients on Ocrelizumab and Other Disease‐Modifying Therapies: A Multi‐Ethnic Observational Study
- (2022) Ilya Kister et al. ANNALS OF NEUROLOGY
- Disease modifying therapies and Covid‐19 severity in Multiple Sclerosis
- (2021) Maria Pia Sormani et al. ANNALS OF NEUROLOGY
- Robust SARS-CoV-2-specific T cell immunity is maintained at 6 months following primary infection
- (2021) Jianmin Zuo et al. NATURE IMMUNOLOGY
- Cellular and humoral immune responses following SARS-CoV-2 mRNA vaccination in patients with multiple sclerosis on anti-CD20 therapy
- (2021) Sokratis A. Apostolidis et al. NATURE MEDICINE
- Humoral and T-Cell Response to SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis Treated With Ocrelizumab
- (2021) Livnat Brill et al. JAMA Neurology
- Development of humoral and cellular immunological memory against SARS-CoV-2 despite B cell depleting treatment in multiple sclerosis
- (2021) Klara Asplund Högelin et al. iScience
- Humoral immune response in multiple sclerosis patients following PfizerBNT162b2 COVID19 vaccination: Up to 6 months cross-sectional study
- (2021) Anat Achiron et al. JOURNAL OF NEUROIMMUNOLOGY
- Humoral- and T-Cell–Specific Immune Responses to SARS-CoV-2 mRNA Vaccination in Patients With MS Using Different Disease-Modifying Therapies
- (2021) Carla Tortorella et al. NEUROLOGY
- T-cell responses to SARS-CoV-2 in multiple sclerosis patients treated with ocrelizumab healed from COVID-19 with absent or low anti-spike antibody titers
- (2021) Marco Iannetta et al. Multiple Sclerosis and Related Disorders
- BNT162b2 vaccination induces durable SARS-CoV-2–specific T cells with a stem cell memory phenotype
- (2021) Gisella Guerrera et al. Science Immunology
- An Italian programme for COVID-19 infection in multiple sclerosis
- (2020) Maria Pia Sormani LANCET NEUROLOGY
- SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls
- (2020) Nina Le Bert et al. NATURE
- Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumonia
- (2020) Sara De Biasi et al. Nature Communications
- Phenotype and kinetics of SARS-CoV-2-specific T cells in COVID-19 patients with acute respiratory distress syndrome
- (2020) Daniela Weiskopf et al. Science Immunology
- T memory stem cells in health and disease
- (2017) Luca Gattinoni et al. NATURE MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search